Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.971
+0.036 (3.83%)
At close: Jun 26, 2026, 4:00 PM EDT
0.960
-0.011 (-1.16%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Rein Therapeutics Employees
Rein Therapeutics had 10 employees as of December 31, 2025. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
n/a
Profits / Employee
-$5,020,800
Market Cap
90.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
RNTX News
- 17 days ago - Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom - GlobeNewsWire
- 20 days ago - Rein Therapeutics Proxy statement: Proxy filing - Filings
- 20 days ago - Rein Therapeutics Proxy statement: Proxy filing - Filings
- 27 days ago - Rein Therapeutics price target lowered to $8 from $10 at H.C. Wainwright - TheFly
- 4 weeks ago - Rein Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option - GlobeNewsWire
- 6 weeks ago - Rein Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock - GlobeNewsWire